T43.1X2 Category · further specificity required Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm
ICD-10-CM T43.1X2 identifies “Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T43 · Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified
Excludes 26
Seventh character1
The appropriate 7th character is to be added to each code from category T43
A — initial encounter
D — subsequent encounter
S — sequela
More specific codes
T43.1X2APoisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounterBillable / specificT43.1X2DPoisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, subsequent encounterBillable / specificT43.1X2SPoisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, sequelaBillable / specificOfficial index references
Official index references (23)
Amiflamine (1)
- AmiflamineDrugs and chemicals
Antidepressant (1)
- Antidepressant › monoamine oxidase inhibitorDrugs and chemicals
Clorgiline (1)
- ClorgilineDrugs and chemicals
Hydrazine (1)
- Hydrazine › monoamine oxidase inhibitorsDrugs and chemicals
Inhibitor (2)
- Inhibitor › monoamine oxidase NECDrugs and chemicals
- Inhibitor › monoamine oxidase NEC › hydrazineDrugs and chemicals
Iproclozide (1)
- IproclozideDrugs and chemicals
Iproniazid (1)
- IproniazidDrugs and chemicals
Isocarboxazid (1)
- IsocarboxazidDrugs and chemicals
MAO inhibitors (1)
- MAO inhibitorsDrugs and chemicals
Marplan (1)
- MarplanDrugs and chemicals
Marsilid (1)
- MarsilidDrugs and chemicals
Mebanazine (1)
- MebanazineDrugs and chemicals
Moclobemide (1)
- MoclobemideDrugs and chemicals
Monoamine oxidase inhibitor NEC (2)
- Monoamine oxidase inhibitor NECDrugs and chemicals
- Monoamine oxidase inhibitor NEC › hydrazineDrugs and chemicals
Nardil (1)
- NardilDrugs and chemicals
Nialamide (1)
- NialamideDrugs and chemicals
Parnate (1)
- ParnateDrugs and chemicals
Phenelzine (1)
- PhenelzineDrugs and chemicals
Pheniprazine (1)
- PheniprazineDrugs and chemicals
Safrazine (1)
- SafrazineDrugs and chemicals
Tranylcypromine (1)
- TranylcypromineDrugs and chemicals
History
Code history
Latest recorded change · FY2026 · April
Effective from
- Inherited rules changed
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm
Category — select a more specific code
CDC/NCHS · FY2026 · AprilAll editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | Inherited rules changed |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.